EANS-Adhoc: CURANUM AG
Changes to the Chairmanship of the Management Board of
CURANUM AG
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.
Company Information/Changes to the Chairmanship of the Management Board of CURANUM AG
03.09.2010
Unscheduled announcement
Changes to the Chairmanship of the Management Board of CURANUM AG
CURANUM AG, Munich, announces that the Supervisory Board has today removed Mr. Bernd Rothe from his position as Chairman of the Management Board (CEO), and has also removed him from the Management Board with immediate effect, as well as relieving him from all duties within the Group.
The Supervisory Board plans to appoint and announce his successor within the next weeks. Until then, Mr. Rothe's duties will be exercised by Management Board members Mrs. Judith Barth (CFO) and Mrs. Sabine Weirich (COO).
Munich, September 3, 2010
The Management Board
end of announcement euro adhoc
Further inquiry note:
Bettina Pöschl
Tel. +49(0)89-242065-69
E-Mail: bettina.poeschl@curanum.de
Branche: Healthcare Providers
ISIN: DE0005240709
WKN: 524070
Index: CDAX, Classic All Share, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / regulated dealing